{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:08:49Z","timestamp":1785434929251,"version":"3.56.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Membranous nephropathy (MN) is an important and common cause of nephrotic syndrome in adults. Overlap syndrome is an infrequent clinical subgroup characterized by the coexistence of autoimmune hepatitis, primary biliary cholangitis or primary sclerosing cholangitis. Coexistence of MN and autoimmune liver diseases is rare. Several reports have documented the concurrent presence of multiple autoimmune diseases, suggesting a potential mechanism linking these disorders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient\u2019s concerns:<\/jats:title>\n            <jats:p>A 53-year-old male patient diagnosed with phospholipase A2 receptor-related MN accompanied by recurrent increases in aminotransferases during treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient was finally diagnosed as MN with primary biliary cholangitis-autoimmune hepatitis overlap syndrome based on histopathological findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>A combination of rituximab, oral methylprednisolone, and ursodeoxycholic acid.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient achieved complete immunological remission and partial remission of proteinuria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We encountered a unique case with autoimmune disease of both liver and kidney. Treatment plans should be tailored to each patient\u2019s specific condition since there is no standard protocol. The pathological mechanisms of overlapping autoimmune diseases require further understanding.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000042770","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:02:29Z","timestamp":1754089349000},"page":"e42770","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A case of membranous nephropathy complicated by autoimmune hepatitis and primary biliary cholangitis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5608-4352","authenticated-orcid":false,"given":"Xiwen","family":"Lei","sequence":"first","affiliation":[{"name":"Department of Pathology, The PLA Naval Medical University, Shanghai Changhai Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-2342","authenticated-orcid":false,"given":"Rui","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The PLA Naval Medical University, Shanghai Changhai Hospital, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The PLA Naval Medical University, Shanghai Changhai Hospital, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoxia","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pathology, The PLA Naval Medical University, Shanghai Changhai Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The PLA Naval Medical University, Shanghai Changhai Hospital, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy.","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.ajkd.2020.10.009","article-title":"Membranous nephropathy: core curriculum 2021.","volume":"77","author":"Alsharhan","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2022.06.007","article-title":"The inconvenient truth of primary biliary cholangitis\/autoimmune hepatitis overlap syndrome.","volume":"26","author":"Hussain","year":"2022","journal-title":"Clin Liver Dis"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities.","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5021\/ad.2020.32.1.69","article-title":"Diffuse systemic sclerosis in a patient with primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: a case report.","volume":"32","author":"Han","year":"2020","journal-title":"Ann Dermatol"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"1132072","DOI":"10.3389\/fimmu.2023.1132072","article-title":"Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MEG.0b013e328350f95b","article-title":"Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.","volume":"24","author":"Efe","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.kint.2023.06.032","article-title":"Mayo clinic consensus report on membranous nephropathy: proposal for a novel classification.","volume":"104","author":"Sethi","year":"2023","journal-title":"Kidney Int"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis.","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ndt\/gfad225","article-title":"Membranous nephropathy treatment standard.","volume":"39","author":"Radhakrishnan","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ekir.2022.12.011","article-title":"Novel treatments paradigms: membranous nephropathy.","volume":"8","author":"Rojas-Rivera","year":"2023","journal-title":"Kidney Int Rep"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"e070201","DOI":"10.1136\/bmj-2022-070201","article-title":"Diagnosis and management of autoimmune hepatitis.","volume":"380","author":"Muratori","year":"2023","journal-title":"BMJ"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1542\/peds.2011-1900","article-title":"Successful treatment of refractory autoimmune hepatitis with rituximab.","volume":"132","author":"D\u2019Agostino","year":"2013","journal-title":"Pediatrics"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy.","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhepr.2019.10.005","article-title":"Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: results from the international autoimmune hepatitis group.","volume":"1","author":"Than","year":"2019","journal-title":"JHEP Rep"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/hep.30906","article-title":"Fatigue in primary biliary cholangitis: no place for rituximab.","volume":"70","author":"Beuers","year":"2019","journal-title":"Hepatology"},{"key":"R20-20250918","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/hep.30099","article-title":"Rituximab is ineffective for treatment of fatigue in primary biliary cholangitis: a phase 2 randomized controlled trial.","volume":"70","author":"Khanna","year":"2019","journal-title":"Hepatology"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4067\/S0034-98872011001100015","article-title":"Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome.","volume":"139","author":"Carey","year":"2011","journal-title":"Rev Med Chil"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5414\/CN110892","article-title":"Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: a case report. CN.","volume":"99","author":"Hong","year":"2023","journal-title":"Clin Nephrol"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/liv.15382","article-title":"Extrahepatic autoimmune diseases in autoimmune hepatitis: effect on mortality.","volume":"42","author":"Birn-Rydder","year":"2022","journal-title":"Liver Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:01:44Z","timestamp":1758232904000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":21,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042770","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"2024-11-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}